These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6489764)

  • 41. Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies.
    Krishna R; Anderson MS; Bergman AJ; Jin B; Fallon M; Cote J; Rosko K; Chavez-Eng C; Lutz R; Bloomfield DM; Gutierrez M; Doherty J; Bieberdorf F; Chodakewitz J; Gottesdiener KM; Wagner JA
    Lancet; 2007 Dec; 370(9603):1907-14. PubMed ID: 18068514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydergine in senile mental impairment.
    Loew DM; Weil C
    Gerontology; 1982; 28(1):54-74. PubMed ID: 7037548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodynamic effects of lactotripeptides from casein hydrolysate in Mediterranean normotensive subjects and patients with high-normal blood pressure: a randomized, double-blind, crossover clinical trial.
    Cicero AF; Rosticci M; Veronesi M; Bacchelli S; Strocchi E; Melegari C; Grandi E; Borghi C
    J Med Food; 2010 Dec; 13(6):1363-8. PubMed ID: 21091250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioavailability of slow-release co-dergocrine mesylate (dihydroergotoxine) formulations.
    Woodcock BG; Habedank WD; Loh W; Herrmann W; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):660-3. PubMed ID: 3436686
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
    Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM
    Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steady state bioavailability of a new oral formulation of Hydergine in geriatric patients.
    Sörgel F; Abisch E; Dennler HJ; Lang E
    Eur J Clin Pharmacol; 1984; 26(1):133-5. PubMed ID: 6714287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Changes produced by age in cardiovascular reflex responses].
    Romero-Vecchione E; Wessolosky M; Lupi J; Vásquez J; Velasco M; Gómez J
    Invest Clin; 1993; 34(4):193-208. PubMed ID: 8003537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Red wine polyphenols do not lower peripheral or central blood pressure in high normal blood pressure and hypertension.
    Botden IP; Draijer R; Westerhof BE; Rutten JH; Langendonk JG; Sijbrands EJ; Danser AH; Zock PL; van den Meiracker AH
    Am J Hypertens; 2012 Jun; 25(6):718-23. PubMed ID: 22421906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effect of oral alpha-lipoic acid in overweight/obese individuals on brachial-ankle pulse wave velocity and supine blood pressure: a randomized, crossover, double-blind, placebo-controlled trial].
    Huang YD; Li N; Zhang WG; Hu XJ; Wang Q; Wang CC; Xu RW; Yan K; Hou XY; Naerkeze ; Wang XL; Yan WL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Mar; 32(3):290-6. PubMed ID: 21457668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effect of sufentanil in high doses on hemodynamics and electroencephalography activity in coronary patients].
    Stephan H; Sonntag H; Lange H; Lüpke K
    Anaesthesist; 1989 Oct; 38(10):510-8. PubMed ID: 2531557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinical pharmacology of dihydroergotoxine mesylate (Hydergine).
    James IM
    Br J Clin Pract Suppl; 1985 Jun; 39():21-4. PubMed ID: 3929811
    [No Abstract]   [Full Text] [Related]  

  • 59. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of efficacy of hydergine in patients with Alzheimer's disease.
    Thompson TL; Filley CM; Mitchell WD; Culig KM; LoVerde M; Byyny RL
    N Engl J Med; 1990 Aug; 323(7):445-8. PubMed ID: 2082953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.